Hypoloc Comp

Hydrochlorothiazide / Nebivolol, the active ingredient in Hypoloc Comp, is a thiazide diuretic and beta‑blocker combination presented as an oral tablet for oral use. It is used to lower elevated blood pressure in adult patients. The combination leverages the diuretic effect of hydrochlorothiazide together with the cardio‑selective beta‑blockade and nitric‑oxide mediated vasodilation of nebivolol to achieve a synergistic antihypertensive effect.

GNH USA supplies Hypoloc Comp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with European Union marketing authorisation standards and is distributed under strict Good Distribution Practice guidelines.

Hypoloc Comp is indicated for the management of hypertension, acting on the vascular and renal pathways that regulate blood pressure. - Hypertension (essential): lowers systolic and diastolic pressure in adults. - Stage 1 hypertension: helps achieve target blood pressure when lifestyle measures are insufficient. - Stage 2 hypertension: provides additional control when monotherapy does not reach goals.

Common Side Effects: - Dizziness or light‑headedness. - Increased urinary frequency. - Headache. - Fatigue or mild weakness. - Electrolyte disturbances such as low potassium. - Mild sexual dysfunction.

Serious or Rare Side Effects: - Severe hypotension. - Acute kidney injury or significant rise in serum creatinine. - Marked electrolyte imbalances (hyponatremia, hypokalemia, hyperuricemia). - Bradycardia or heart block. - Allergic reactions including rash, angioedema, or anaphylaxis. - Liver function abnormalities.

Before initiating therapy, clinicians should consider the following precautions: - Blood pressure monitoring: ensure adequate control without excessive drop. - Electrolyte assessment: check serum potassium and sodium regularly. - Renal function: evaluate creatinine clearance, especially in patients with chronic kidney disease. - Diabetes mellitus: monitor blood glucose as thiazides may affect glycemic control. - Abrupt discontinuation: taper gradually to avoid rebound hypertension. - Store at below 25°C: keep in the original pack, protect from moisture.

Potential drug interactions must be reviewed prior to prescribing. Major Interactions (Avoid): - Concomitant use with other antihypertensives may cause profound hypotension. - NSAIDs can diminish the diuretic effect of hydrochlorothiazide. - Potassium‑sparing diuretics may lead to hyperkalemia. - Strong CYP2D6 inhibitors (e.g., paroxetine) can increase nebivolol plasma levels. - Lithium therapy may result in increased lithium toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs may enhance renal effects and potassium changes. - Other beta‑blockers can add to bradycardia risk. - Digoxin levels may be altered by changes in electrolytes. - Antidiabetic agents may require dose adjustment due to thiazide‑induced hyperglycemia. - Antidepressants that affect serotonin may increase risk of hyponatremia.